Ecomike
4 months ago
I prefer to wait, with no action, until they score the right deal, the right, new CEO and moving forward business plan.
If they suddenly come out with an FDA Phase 3 approved trial, or product line and marketing deal, that will wake up the dead and sleepers here waiting patiently.
The lack of volume is most encouraging, as it means no one is or has been trying sell the unrestricted shares, and they can not sell them with out volume, or news. Real investors do not worry about volume or share price, they care about the business plan and who is steering the ship.
Ecomike
4 months ago
OTC Markets says $NDTP is not a shell. Financials say it is not a shell. Guess you forgot to check before mouthing off here?
whatever, all these shells are dog crap
Sounds like something a short in trouble would say?
Facts:
No one is selling. Volume is almost nonexistent because longs know what they own, and have been patient here since Covid19 started and delayed everything. Three of the largest insider restricted shareholders that own about 80% of the OS as restricted shares are and or were, top officials in Nasdaq and NYSE Billion dollar firms, with impeccable credentials, and have never sold any shares. The current CEO is just a substitute because of the health Issues the founder had that benched him.
The serious lack of volume is good news IMO, as it means they are working on finding a new Dr. Mark Kester and real Bio-Tech CEO to run this company.
It is also possible they could finally file an SEC Form 10 next year, and go to audited SEC reporting, if they have new people and funding to onboard and take over.
The fact they ignored offers from us to take over, speaks volumes.
Ecomike
4 months ago
The fact there is no real volume, and no news, is a very good sign. If there was going to be dumping, they would have started a long time ago.
They found and recruted Dr. Michael W. Fountain and teamed up with him in 2010-2013, but his Liposomal patent that $NDTP would have gotten failed in the US Patent office, and another inventor won the patent that makes drinks.
Insiders bought MF's shares and they replaced Dr. Michael W. Fountain with the next newer, slightly younger(?) Nano Particle (Ceramide) genius Dr. Mark Kester, who had a phase III FDA approved non Toxic Ceramide Nano Tech, cancer cell killing technology ready to go.
The NDTP filings say that the plan was indeed, as I had speculated here earlier, to bring in and fund the Dr. Mark Kester Phase III approved for trials, cancer cure. Then Dr. Mark Kester suddenly died, shortly after the founder CEO (Hovis) had multiple strokes.
Shit happens. It was a huge loss for us and the world. So they had to rush and get the current CEO to come back and fill the CEO spot, before NDTP ended up dead again, after the founder CEO had the strokes.
The latest update was that we now own the original Nano Particle complex technology that CCA, LLC and NDTP owns per the filings the UPennMed TBI research Hospital JV work NDTP (previously CCA, LLC) developed, and was going to target TBI. That is why NDTP is not a shell, and OTC Markets has listed it as not a shell.
The FED rate hikes 2 years ago killed funding in the Bio-Tech/Drug world, and now FED rates are about to go into full reverse. That is good news for us, as money will move back into riskier assets, and not just US Treasuries..
$NDTP needs a real, experienced drug development CEO Pro and MD/Scientist to take over the reigns and the money to do it.
The Insiders, did this 2 times before, and IMO, are head hunting quietly for the best options.
Ecomike
4 months ago
One can not replace a brilliant top gun, Dr. Mark Kester, overnight. Dr. Mark Kester, who suddenly, unexpectedly, passed away in late 2023, was the founder of the Pennsylvania State Bio-tech research center, with more patents than Carter has pills.
He reached a phase III FDA approved Non Toxic Nano Particle Ceramide, cancer killing technology stage, just before the Pandemic stalled everything. The Founder CEO, Hovis, had multiple strokes months before Dr. Kester died, and Hovis had to be quickly replaced. Only one person was able to that in time, the current CEO.
Our Best hope is that the founders (not the current CEO), Insiders that own over 90% of the OS, find a new Dr. Mark Kester, and a new top gun, Nasdaq worthy Bio-tech operating CEO, to take over and move the company forward. The current CEO is just an OTC experienced, temp, and has no Bio-tech, Medical experience.
I would rather they take their time, and get the best team lined up, rather that rush it, and risk making mistakes.
Ecomike
8 months ago
Yes it is possible. No amendment is needed.
Insiders that held 5% ceased to be insiders when the OS increased and are not required to be, or allowed to be listed, unless they are officers or directors.
Those with less than 5% that were reported early on in past years as newly issued share holders from the R/M, did not need to be reported again since the first report
since they did not own 5% or more of the OS.
The CEO has no control over the removal of restrictions on restricted shares. The TA does, not the CEO.
And removal of the restrictions requires an attorney letter that has a huge $$$$ cost.
Even then there is almost zero way to get OTC shares into the market and sold once they are unrestricted since the SEC changed the laws in 2021.
Good luck finding a broker that will even take them, unless the stock is on Nasdaq.
ChaseDog31
8 months ago
Not every insider can have the same number of restricted shares in the Q1 report as they had in the Q4 report, Passalaqua. Tens of millions of insider shares went unrestricted in Q1 without any change in the total outstanding shares, and yet all the insiders show the same number of restricted shares in your chart. Not possible. You need to amend this report yet again, a quarterly occurence for you.
You not only steal tens of millions of shares from the company treasury to reimburse staples and scotch tape, you have the accounting skills of a 3rd grader and the focus of a Jack Russell puppy.
You are unfit to be the CEO of an ice cream truck, let alone a pharmaceuticul company. Let's hope the complaint i filed about your criminality gets to the top of someone's inbasket in short order so this long nightmare of larceny and zero leadership here ends post haste. I am ready to testify as lead complainant.
Ecomike
8 months ago
The current CEO's, issued to himself shares, are still a crime under New York State law where he lives. It is Usury law he violated.
If he does not cancel them he can end up in jail...
The Hovis mass issued shares, are a different issue.
They could still some day prove they were justified if NDTP suddenly becomes a major TBI Bio-Tech firm..
So for now I wait...
But lately I doubt it, because if they do, it proves once again this CEO perjured himself in prior filings when he tried to
run that EU cancer scam, cook the books deal..
Question is, did the Insiders, desperate to replace a dying CEO, trust a scum bag to keep NDTP current, one that back stabbed them later? Or did he issue those shares to himself, for extortion, or similar purposes...
At least the stock is Pink Current, and not dead...
Ecomike
8 months ago
Dude, CEOs have no control over the unrestricting of restricted shares.
It takes an attorney letter opinion, Proof of when and how they were bought, and TA approval,
The CEO's share are all still restricted, 100% of the listed Insiders including LK, with 10% or more of the OS are stuck until they reach Nasdaq.
The small fry with less than 5% of the OS, no longer listed as 5% or more insiders, are the unrestricted shares.
No major US Brokers will take those OTC shares anymore, until they are Nasdaq shares (call them and ask, Fidelity, Schwab, E-Turd)
And if they use a low life not in the US firm, the MM's are only allowed to sell 10% of the prior days volume of them.
They are just as stuck as everyone else. The lack of volume, and rally is very telling IMO.
Ecomike
10 months ago
May be time for me to offer the CEO .00025/share for his shares, double his money, give him a legit exit plan, and let us take over,
and do something real here.
I figured out where to file and get the State of New York to lock up his ill gotten shares and fine him for real money, for violating state law
for loan sharking. Several OTC stock insiders got nailed the last 4 years under New York law, where the Superior Court of NY,
forced the insiders to return and cancel shares. Might be able to do the same for all the other NDTP insiders shares issued at the obscene Loan sharking rates...
I obviously got their attention over the IRS threat, based on the corrected filings for last year.... Where they amended the filings.
So they did read what we posted, and did a CYA fillings amended filings...
Only thing holding me back is that even the recently unrestricted shares have not sold any to retail for 3-6 months.
Why?
Are they close to a deal to clean up this mess and do something real? All they need is a Real Operating CEO and business plan.
This is not the only OTC ticker that suffered Chaos and Mayhem the last 4 years